Heart Failure Acute
30
8
9
5
Key Insights
Highlights
Success Rate
63% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
10.0%
3 terminated out of 30 trials
62.5%
-24.0% vs benchmark
23%
7 trials in Phase 3/4
100%
5 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (30)
Vexus Assessment and Natriuresis-guided Diuretic Therapy in Acute Heart Failure
Contrast-Induced Acute Kidney Injury Prevention in Acute Heart Failure
Evaluation and Support Care Process Within the Care Pathway of Heart Failure Patients
Investigating a Tailored Diuretic Algorithm in Acute Heart Failure Patients
Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure
Congestion and LActate at diScHarge in Acute Heart Failure
Cardiac point-of Care Ultrasound Training Pathway for Emergency Department Advanced Practice Providers
Remote Monitoring After Heart Failure
Evaluation of the Effectiveness of the CardioStory Device in Distinguishing Heart Failure From Other Causes in Patients Presenting With Dyspnea
Prediction of Heart-Failure with Machine Learning
Nitroglycerin vs. Furosemide Using Lung Ultrasound Pilot Trial
SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF
B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure Pilot Trial
Prognostic Model Heart Failure
Pragmatic Urinary Sodium-based Treatment algoritHm in Acute Heart Failure
Effects of Empagliflozin on Clinical Outcomes in Patients With Acute Decompensated Heart Failure
Acetazolamide or Metolazone in Acute Heart Failure
Lesser Poland Cracovian Heart Failure Registry
SGLT2 Inhibitors in Patients With ADHF During Ventilator Weaning
Strain for Risk Assessment and Therapeutic Strategies in Patients With Acute Heart Failure (STRATS-AHF) Registry